Atrial natriuretic peptide modulates alveolar type 2 cell adenylyl and guanylyl cyclases and inhibits surfactant secretion

被引:12
作者
Panchenko, MP
Joyce-Brady, M
Starikova, MG
Oakes, SM
Adachi, R
Brody, JS
Dickey, BF
机构
[1] Vet Affairs Med Ctr, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Med, Pulm & Crit Care Sect, Houston, TX 77030 USA
[3] Baylor Coll Med, Dept Cell Biol, Pulm & Crit Care Sect, Houston, TX 77030 USA
[4] Cardiol Res Ctr, Mol Endocrinol Lab, Moscow 121552, Russia
[5] Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118 USA
[6] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH | 1998年 / 1403卷 / 01期
关键词
atrial natriuretic peptide; adenylyl cyclase; guanylyl cyclase; lung epithelial type 2 cell; surfactant; secretion;
D O I
10.1016/S0167-4889(98)00023-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Alveolar epithelial type 2 (T2) cells isolated from the lungs of adult rats responded to exogenous atrial natriuretic peptide (ANP) by two signalling mechanisms. First, ANP induced a dose-dependent reduction of ligand-stimulated adenylyl cyclase activity and cAMP accumulation. This effect was inhibited by the addition of GDP beta S or by pretreatment with pertussis toxin (PT), consistent with mediation by a Gi protein(s). PT-catalyzed [P-32]ADP-ribosylation, immunoblots with specific antisera, and Northern blot analysis demonstrated that T2 cells contain the G-proteins Gi(2) and Gi(3) which could transduce this signal. ANP also promoted PT-insensitive, dose-dependent accumulation of cGMP, consistent with activation of a receptor guanylyl cyclase. Isoproterenol-stimulated phosphatidylcholine secretion was markedly attenuated by ANP, and this effect was inhibited by PT pretreatment, consistent with mediation by a Gi protein(s). These data indicate that in addition to the lung being a major clearance organ for circulating ANP, lung parenchymal cells are targets of ANP action. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:115 / 125
页数:11
相关论文
共 31 条
[21]   Ca2+ induced surfactant secretion in alveolar type II cultures isolated from the H-2Kb-tsA58 transgenic mouse [J].
Jennings, P ;
Bertocchi, C ;
Frick, M ;
Haller, T ;
Pfaller, W ;
Dietl, P .
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2005, 15 (1-4) :159-166
[22]   ATRIAL NATRIURETIC PEPTIDE(31-67) INHIBITS NA plus TRANSPORT IN RABBIT INNER MEDULLARY COLLECTING DUCT CELLS - ROLE OF PROSTAGLANDIN-E2 [J].
GUNNING, ME ;
BRADY, HR ;
OTUECHERE, G ;
BRENNER, BM ;
ZEIDEL, ML .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 89 (05) :1411-1417
[23]   Exenatide infusion decreases atrial natriuretic peptide levels by reducing cardiac filling pressures in type 2 diabetes patients with decompensated congestive heart failure [J].
Nathanson, David ;
Frick, Mats ;
Ullman, Bengt ;
Nystrom, Thomas .
DIABETOLOGY & METABOLIC SYNDROME, 2016, 8
[24]   Exenatide infusion decreases atrial natriuretic peptide levels by reducing cardiac filling pressures in type 2 diabetes patients with decompensated congestive heart failure [J].
David Nathanson ;
Mats Frick ;
Bengt Ullman ;
Thomas Nyström .
Diabetology & Metabolic Syndrome, 8
[25]   NATRIURETIC PEPTIDES INHIBIT NICOTINE-INDUCED WHOLE-CELL CURRENTS AND CATECHOLAMINE SECRETION IN BOVINE CHROMAFFIN CELLS - EVIDENCE FOR THE INVOLVEMENT OF THE ATRIAL-NATRIURETIC-FACTOR R(2) RECEPTORS [J].
BABINSKI, K ;
HADDAD, P ;
VALLERAND, D ;
MCNICOLL, N ;
DELEAN, A ;
ONG, H .
JOURNAL OF NEUROCHEMISTRY, 1995, 64 (03) :1080-1087
[26]   Effects of chronic elevation of atrial natriuretic peptide and free fatty acid levels in the induction of type 2 diabetes mellitus and insulin resistance in patients with mitral valve disease [J].
Monti, L. D. ;
Lucotti, P. C. G. ;
Setola, E. ;
Rossodivita, A. ;
Pala, M. G. ;
Galluccio, E. ;
LaCanna, G. ;
Castiglioni, A. ;
Cannoletta, M. ;
Meloni, C. ;
Zavaroni, I. ;
Bosi, E. ;
Alfieri, O. ;
Piatti, P. M. .
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2012, 22 (01) :58-65
[27]   Expression of guanylyl cyclase-B (GC-B/NPR2) receptors in normal human fetal pituitaries and human pituitary adenomas implicates a role for C-type natriuretic peptide [J].
Thompson, Iain R. ;
Chand, Annisa N. ;
King, Peter J. ;
Ansorge, Olaf ;
Karavitaki, Niki ;
Jones, Ceri Alexander ;
Rahmutula, Dolkun ;
Gardner, David G. ;
Zivkovic, Vladimir ;
Wheeler-Jones, Caroline P. ;
McGonnell, Imelda M. ;
Korbonits, Marta ;
Anderson, Richard A. ;
Wass, John A. H. ;
McNeilly, Alan S. ;
Fowkes, Robert C. .
ENDOCRINE-RELATED CANCER, 2012, 19 (04) :497-508
[28]   ATRIAL-NATRIURETIC-PEPTIDE SUPPRESSES ISOPRENALINE AND DIBUTYRYL CYCLIC ADENOSINE MONOPHOSPHATE-INDUCED CELL-GROWTH IN CULTURED RENIN-SECRETING HUMAN NEPHROBLASTOMA CELLS - COMPARISON WITH FORSKOLIN-INDUCED RENIN SECRETION [J].
DEVLIN, AM ;
LECKIE, BJ .
JOURNAL OF HYPERTENSION, 1992, 10 (05) :445-450
[29]   The WNT/Ca2+ pathway promotes atrial natriuretic peptide secretion by activating protein kinase C/transforming growth factor-? activated kinase 1/activating transcription factor 2 signaling in isolated beating rat atria [J].
Li, Zhi-Yu ;
Liu, Ying ;
Han, Zhuo-Na ;
Li, Xiang ;
Wang, Yue-Ying ;
Cui, Xun ;
Zhang, Ying .
KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY, 2022, 26 (06) :469-478
[30]   Atrial natriuretic peptide provokes a dramatic increase in cyclic GMP formation and markedly inhibits muscarinic-stimulated Ca2+ mobilisation in SV-40 transformed cat iris sphincter smooth muscle (SV-CISM-2) cells [J].
Ding, KH ;
Ali, N ;
Abdel-Latif, AA .
CELLULAR SIGNALLING, 1999, 11 (02) :87-94